Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC
It’s a medical marijuana company helping over 80,000 patients and you may have never heard of it. Jim Cramer looks into Trulieve and what it can tell us about the…
ETF Spotlight: Aurora cannabis hit by pandemic-related restrictions
CNBC’s Morgan Brennan takes a look at cannabis-focused ETFs and the dip in Aurora shares. For access to live and exclusive video from CNBC subscribe to CNBC PRO: Subscribe to…
Charlotte’s Web Holdings CEO on Canada legalizing cannabis
Hesaam Moallem, Charlotte’s Web Holdings CEO, discusses Canada’s legalization of recreational cannabis and how it might effect the CBD industry.
Canopy Growth CEO on cannabis sell-off
Bruce Linton, Canopy Growth CEO, discusses the volatile moves in cannabis stocks just a week after Canada legalized recreational marijuana use.
Green Growth mulls takeover bid for Canadian cannabis company Aphria
CNBC’s Aditi Roy discusses Green Growth’s takeover bid of Canadian cannabis company Aphria following the country’s legalization of marijuana this year. Subscribe to CNBC: About CNBC: From ‘Wall Street’ to…
GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC
Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…
How illegal dispensaries are a threat to the legal cannabis industry
The booming business of cannabis is what many investors are calling the new gold rush. But with those potential riches comes this reality: there’s a much bigger boom in the…
US Officials could be ready to crack down on cannabis craze
Are US border officials cracking down on the cannabis industry? Pot stocks get smoked. With CNBC’s Aditi Roy and Scott Wapner, and the Fast Money traders, Pete Najarian, Tim Seymour,…
How midterm elections could impact the cannabis business
Vivien Azer, Cowen senior research analyst, and CNBC’s Aditi Roy join ‘Squawk Alley’ to discuss how cannabis regulation could be affected by the midterm elections, specifically in Utah, North Dakota,…
Pot legislation is more likely in 2020, 2021 than this year: Cannabis analyst
CNBC’s “Squawk Alley” team talks about legislation that would legalize cannabis and what that means for cannabis companies with Vivien Azer, Cowen’s senior cannabis and beverage sector analyst.